经腔道对接金属支架行ERCP的多中心观察研究
该多中心观察研究纳入30例同时存在胃出口梗阻和胆道梗阻的患者,在EUS引导下放置腔道对接金属支架(LAMS)后经支架行ERCP。技术成功率为90%,最常见操作为胆道支架置入或更换(87%),不良事件发生率为13%。结论认为经胃肠LAMS行ERCP是安全有效的选择。
要点
- 经LAMS行ERCP技术成功率达90%,可用于胃出口梗阻合并胆道梗阻。
- 最常见干预为胆道支架置入或更换,占87%。
- 不良事件发生率为13%,包括出血和LAMS移位。
核心结论
- 经胃肠LAMS行ERCP是处理同时性胃出口梗阻和胆道梗阻的安全有效选项。
研究设计与样本
- 多中心观察性研究,纳入3家医院2016年6月至2025年3月期间接受EUS引导下胃肠吻合(EUS-GE)并放置LAMS、随后经LAMS行ERCP的胃出口梗阻合并胆道梗阻患者,共30例。
主要发现
- EUS-GE使用15-mm LAMS者17例(57%),使用20-mm LAMS者13例(43%)。
- EUS-GE与ERCP之间的中位时间为39天。
- 技术成功27例(90%),最常见干预为胆道支架置入或更换(26例,87%)。
- 共发生4例(13%)不良事件,包括出血和LAMS移位。
临床怎么用
- 对于同时存在胃出口梗阻和胆道梗阻的患者,可考虑经EUS-GE放置的LAMS行ERCP。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: We describe our multicenter experience with endoscopic retrograde cholangiopancreatography (ERCP) performed via a lumen-apposing metal stent (LAMS) for the management of coincident gastric outlet obstruction (GOO) and biliary obstruction. METHODS: Patients with GOO and biliary obstruction who underwent EUS guided gastroenterostomy (EUS-GE) with a LAMS and ERCP via the LAMS at 3 hospitals from June 2016 to March 2025 were included. Baseline variables, interventions, outcomes, and adverse events (AEs) were characterized using descriptive statistics. RESULTS: We included 30 patients. EUS-GEs were performed with 15-mm (n = 17, 57%) and 20-mm LAMSs (n = 13, 43%). The median time between EUS-GE and ERCP was 39 days. Technical success was achieved in 27 patients (90%). The most common intervention was biliary stent insertion or exchange (n = 26, 87%). There were 4 (13%) AEs (bleeding and LAMS dislodgement). CONCLUSIONS: ERCP performed via a gastroenteric LAMS is a safe and effective option for the management of coincident GOO and biliary obstruction.
引用
- Khan R, Hosari R, Khashab MA, et al. Outcomes of endoscopic retrograde cholangiopancreatography performed via a lumen-apposing gastroenterostomy stent: a multicenter observational study (with videos). Gastrointest Endosc. 2025. PMID: 41183599. doi:10.1016/j.gie.2025.10.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。